Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Antiangiogenic activity of trabectedin in myxoid liposarcoma: Involvement of host TIMP-1 and TIMP-2 and tumor thrombospondin-1.
[liposarcoma]
Trabectedin
is
a
marine
natural
product
,
approved
in
Europe
for
the
treatment
of
soft
tissue
sarcoma
and
relapsed
ovarian
cancer
.
Clinical
and
experimental
evidence
indicates
that
trabectedin
is
particularly
effective
against
myxoid
liposarcomas
where
response
is
associated
to
regression
of
capillary
networks
.
Here
,
we
investigated
the
mechanism
of
the
antiangiogenic
activity
of
trabectedin
in
myxoid
liposarcomas
.
Trabectedin
directly
targeted
endothelial
cells
,
impairing
functions
relying
on
extracellular
matrix
remodeling
(
invasion
and
branching
morphogenesis
)
through
the
upregulation
of
the
inhibitors
of
matrix
metalloproteinases
TIMP-
1
and
TIMP-
2
.
Increased
TIMPs
synthesis
by
the
tumor
microenvironment
following
trabectedin
treatment
was
confirmed
in
xenograft
models
of
myxoid
liposarcoma
.
In
addition
,
trabectedin
upregulated
tumor
cell
expression
of
the
endogenous
inhibitor
thrombospondin-
1
(
TSP
-
1
,
a
key
regulator
of
angiogenesis-dependent
dormancy
in
sarcoma
)
,
in
in
vivo
models
of
myxoid
liposarcomas
,
in
vitro
cell
lines
and
primary
cell
cultures
from
patients
'
myxoid
liposarcomas
.
Chromatin
Immunoprecipitation
analysis
showed
that
trabectedin
displaced
the
master
regulator
of
adipogenesis
C
/
EBP
β
from
the
TSP
-
1
promoter
,
indicating
an
association
between
the
up-regulation
of
TSP
-
1
and
induction
of
adipocytic
differentiation
program
by
trabectedin
.
We
conclude
that
trabectedin
inhibits
angiogenesis
through
multiple
mechanisms
,
including
directly
affecting
endothelial
cells
in
the
tumor
microenvironment-with
a
potentially
widespread
activity-and
targeting
tumor
cells
'
angiogenic
activity
,
linked
to
a
tumor
-
specific
molecular
alteration
.
Diseases
Validation
Diseases presenting
"approved in europe for the treatment of soft tissue sarcoma and relapsed ovarian cancer"
symptom
liposarcoma
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom